COLL
XNASCOLLEGIUM PHARMACEUTICAL INC
Avg. sentiment
0.60bullish
1 news · 90d
7d trend
——
0 news · vs previous 7d (—)
Breakdown
↑ 1• 0↓ 0
Sentiment velocity
+0.000→/day
Acceleration —
Sentiment scores computed by AI · Not investment advice.
No price data available for this ticker.
Track $COLL sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 1
How did the price react? →- GlobalNewswire5/12/2026, 11:31:00 AMCollegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
Collegium Pharmaceutical has completed its acquisition of AZSTARYS, an ADHD medication, from Corium Therapeutics. The deal adds a differentiated product to Collegium's existing ADHD portfolio. No financial terms were disclosed in the announcement.
Sentiment 0.60Relevance 100%